Search

Sanofi SA

Uždarymo kaina

SektoriusSveikatos priežiūra

87.81 -0.58

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

87.51

Max

88.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1.1B

3B

Pardavimai

2.9B

15B

P/E

Sektoriaus vid.

25.373

68.089

Pelnas, tenkantis vienai akcijai

3.55

Pelno marža

19.832

Darbuotojai

74,846

EBITDA

957M

5B

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+8.15% upside

Dividendai

By Acuity

Kitas uždarbis

2027-01-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

6.1B

103B

Ankstesnė atidarymo kaina

88.39

Ankstesnė uždarymo kaina

87.81

Sanofi SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-11-13 23:51; UTC

News
Correlated Moves

MaxLinear, Inc. shares are declining in after-market hours, influenced by Nvidia's CEO resignation and broader market sell-off amid rising Treasury yields.

2026-11-13 23:51; UTC

News

Interactive Brokers Group Inc is trading lower in after-market hours, impacted by concerns over Nvidia's CEO resignation and rising Treasury yields.

2026-11-13 23:41; UTC

News

Burlington Stores declines in after-market trading following Deutsche Bank's report, lowering same-store sales growth estimate to 2% due to weather and sales challenges.

2026-11-13 23:36; UTC

News

Cabaletta Bio, Inc. shares advanced in after-market trading following a reported increase earlier in the week related to data on its lead product candidate, Rese-cel.

2026-11-13 23:36; UTC

News

Thermo Fisher Scientific CEO Marc N. Casper will participate in the UBS 2026 CEO Call Series on November 19, 2026, at 8:30 a.m. ET.

2026-11-13 23:31; UTC

News
Correlated Moves

Invesco QQQ is down in after-market hours, moving in sympathy with AMD and other key holdings amid concerns over inflation and NVIDIA CEO's resignation.

2026-11-13 23:22; UTC

News
Correlated Moves

Coinbase Global, Inc. shares are declining in after-market hours, influenced by falling Bitcoin prices and rising U.S. Treasury yields amid inflation concerns.

2026-11-13 23:21; UTC

News

Terex Corporation shares are trading lower in after-market hours, despite refining full-year net sales expectations to $8 billion to $8.2 billion amid broader market pressures.

2026-11-13 23:21; UTC

News

IBM's stock declined in after-market trading amid broader market pressure, following its acquisition of AuthMind and negative sentiment from Nvidia's CEO resignation.

2026-11-13 23:21; UTC

News

RTX Corporation receives a $42.1 million contract modification from the U.S. Department of the Navy for its Next Generation Jammer Mid-Band program.

2026-11-13 23:16; UTC

News

Citigroup maintains Buy rating on Devon Energy but lowers price target to $60, with shares advancing modestly in after-market trading.

2026-11-13 23:06; UTC

News

Xylem Inc. announces a $1.5 billion share repurchase program and declares a fourth-quarter dividend of $0.43 per share, effective immediately.

2026-11-13 23:06; UTC

News

Soros Fund Management LLC has reduced its stake in Apple Inc. by 25.7%, now holding 393.68k shares, according to a report published today.

2026-11-13 23:06; UTC

Macro Event
News

Ethereum is trading lower amid persistent inflation concerns following the U.S. Producer Price Index report and heightened uncertainty from geopolitical tensions.

2026-11-13 23:03; UTC

Macro Event
News

Bitcoin has fallen below $70K for the first time since August, with over $1.3 billion in crypto futures liquidated, primarily from long positions.

2026-11-13 23:02; UTC

News
Correlated Moves

Citigroup announces redemption of $2.2 billion in notes due 2027 and $800 million in floating rate notes, amid broader market concerns.

2026-11-13 23:02; UTC

Social Media
News
Correlated Moves

Upgrade to Outperform from Market Perform by William Blair analyst.

2026-11-13 23:02; UTC

News

Rosenblatt maintains Buy rating on CrowdStrike and raises price target to $275, citing strong demand for its cybersecurity solutions.

2026-11-13 23:02; UTC

News

Soros Fund Management LLC has fully divested its stake in The Walt Disney Company, contributing to the stock's negative price movement in after-market trading.

2026-11-13 23:02; UTC

News
Macro Event

Bitcoin has fallen below $70K for the first time since August, amid $1.3 billion in liquidations of crypto futures and ongoing ETF withdrawals.

2026-11-13 23:02; UTC

Social Media
News
Correlated Moves

NVIDIA's stock declines following CEO Jensen Huang's resignation amid allegations, contributing to a loss exceeding $573 billion in market value.

2026-11-13 23:02; UTC

News
Macro News
Macro Event

Bitcoin trades lower since Thursday's close.

2026-11-13 23:02; UTC

News

IonQ files a prospectus for the resale of approximately 34.6 million shares, raising concerns about potential dilution and its impact on share value.

2026-11-13 23:01; UTC

News
Correlated Moves

United Airlines announces a nationwide ground stop mandated by the FAA, contributing to a negative market response and a notable drop in after-market trading.

2026-11-13 23:01; UTC

News

Riot Platforms, Inc. is declining amid a broader market downturn, with options volume at 226k contracts and a put/call ratio of 0.16.

2026-11-13 23:01; UTC

News

Deutsche Bank lowers TJX's Marmaxx same-store sales growth estimate to 1% from 2%, citing softer sales trends and weather-related disruptions.

2026-11-13 23:01; UTC

News
Correlated Moves

Southwest Airlines hosted its first live gaming tournament on an airplane, utilizing Starlink Wi-Fi, while shares fell in after-hours trading.

2026-11-13 23:01; UTC

News

Northrop Grumman Corp shares declined in after-market trading, following a broader market trend lower amid concerns over inflation and rising Treasury yields.

2026-11-13 23:01; UTC

News
Correlated Moves

Carl Icahn has sold his holding in JetBlue Airways, contributing to negative sentiment as the stock moves lower in after-market trading.

2026-11-13 23:01; UTC

News

Soros Fund Management LLC has dissolved its stake in Lucid Group, Inc., according to an SEC filing released today.

Akcijų palyginimas

Kainos pokytis

Sanofi SA Prognozė

Kainos tikslas

By TipRanks

8.15% į viršų

12 mėnesių prognozė

Vidutinis 95.154 EUR  8.15%

Aukščiausias 110 EUR

Žemiausias 80 EUR

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sanofi SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

14 ratings

8

Pirkti

6

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat